Midgard Science

Labs / Genomics & sequencing

NeoGenomics Laboratories

Fort Myers, FL, United States · neogenomics.com

NeoGenomics Laboratories provides oncology testing and information solutions for healthcare providers, biopharma partners, and patients. It offers disease-state testing, digital pathology, biomarker testing, and oncology data solutions from locations in the United States and the United Kingdom.

Services can be ordered directly on their website, often with listed prices. Their ordering page

What they offer

  • Oncology solutions

    Offers more than 500 oncology tests across major testing modalities for diagnosis, therapy guidance, prognosis, and clinical trial support.

  • PanTracer portfolio

    Provides tissue and liquid biopsy comprehensive genomic profiling for solid tumors, including PanTracer Pro, PanTracer Tissue, PanTracer Tissue + HRD, and PanTracer LBx.

  • RaDaR ST MRD

    Uses personalized circulating tumor DNA testing to detect molecular residual disease and recurrence in blood.

  • Digital pathology

    Provides whole slide imaging and AI-enabled image analysis to support diagnosis and treatment decisions.

  • Biopharma partnerships

    Supports pharma and biotech partners with multi-modal testing solutions, validated methodologies, and project support for drug development and clinical trials.

  • Oncology data solutions

    Uses oncology data from patient profiles to support therapeutic discovery, clinical trial matching, and assessment of therapy outcomes.

  • Pathology solutions

    Offers pathology testing services including immunohistochemistry, flow cytometry, and fluorescence in situ hybridization.

  • Specimen procurement services

    Provides mobile phlebotomy and solid tissue block retrieval services.

What they work on

Modalities
solid tumor, hematologic cancer, liquid biopsy, tissue biopsy, DNA sequencing, RNA sequencing, IHC, FISH, flow cytometry, ctDNA
Species and models
human, cell lines
Assays and studies
single-gene molecular testing, immunohistochemistry (IHC), digital pathology, flow cytometry, fluorescence in situ hybridization (FISH), DNA-based next-generation sequencing (NGS), RNA-based next-generation sequencing (NGS), comprehensive genomic profiling (CGP), liquid biopsy, hematologic testing, PCR
Instruments and platforms
Halo AP® platform
Scale and capacity
over 500 tests, over 2 million patient profiles, over 40,000 unique providers, 4,000 healthcare organizations, 2,200 worldwide staff, 7 locations across 2 continents, more than 120 MDs and PhDs, over 1.7 million cancer-related tests each year, more than 100,000 NGS tests each year, about 4,400 medical sites, more than 500,000 patients
Therapeutic areas
oncology, lung cancer, breast cancer, colorectal cancer, gastric cancer, gynecologic cancer, hematologic cancer, myeloid disorders, aNSCLC, ovarian cancer
Turnaround
8-10 Days · 7 Days · 10 Days · 1-2 Days
What to send
blood draw · solid tissue block · FFPE · unstained slides · peripheral blood smear
Type
testing lab
Sites
Fort Myers, United States · Aliso Viejo, United States · Carlsbad, United States · Ramsey, United States · Durham, United States · Houston, United States · Cambridge, United Kingdom
Team
2,200 worldwide
Quality
CLIA (diagnostic laboratory services in California, Florida, Maryland, New York, Pennsylvania, and Rhode Island) · CAP (selected sites listed on the certifications page) · Medicare provider · Medicaid provider · HTA (United Kingdom site) · ISO 15189 (United Kingdom site)
Serves
United States, United Kingdom
Address
9490 NeoGenomics Way Fort Myers, FL 33912
Founded
1999

Public records

Ownership
NeoGenomics Laboratories, Inc. · US GLEIF
FDA establishment
3015438129
CLIA
03D2240067
FDA drug establishment registration
3015438129 · ANALYSIS source
CMS CLIA laboratory
03D2240067 · SCOTTSDALE source

Similar labs. AGTC Genomics, AtlasXomics, Bio-Me, Biotia

Found in a contract services directory. Listing built from neogenomics.com. Work here? Claim this listing.

NeoGenomics Laboratories · Midgard Science